DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
Baxter International Inc. (NYSE:BAX) recently announced the enrollment of the first group of patients under a U.S. clinical trial for the company’s flagship peritoneal dialysis (PD) solution ...
Please provide your email address to receive an email when new articles are posted on . Baxter International plans to spin off its renal care and acute therapies global business units into an ...
Life Science Industry Research updates its intelligence database by adding 3 new reports "2014 Deep Research Report on Global Peritoneal Dialysis Machine Industry", "2014 Deep Research Report on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results